
Procter & Gambl...


| LII | Sector Avg. | S&P 500 |
|---|---|---|
| 23.25 | 31.60 | 17.70 |
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 9.87 | 48.58 | 51.72 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -10.70 | 0.04 | 0.01 |
| Net Income | 1.90 | 1.18 | 0.29 |
| EPS | 6.10 | 0.92 | 0.24 |
| EBITDA | 270.70M |
| REVENUE | 2.95B |
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $1.18 | $1.21 | $3.44 | $4.02 |
| Number of Analysts | 9 | 8 | 8 | 9 |
| High Estimate | $1.22 | $1.27 | $3.50 | $4.26 |
| Low Estimate | $1.09 | $1.08 | $3.38 | $3.45 |
| Prior Year | $0.96 | $0.97 | $2.70 | $3.44 |
| Growth Rate (Year over Year) | 22.57% | 25.13% | 27.27% | 16.96% |